These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2127064)

  • 41. Delayed anti-arrhythmic effect of nitroglycerin in anesthetized rats: involvement of CGRP, PKC and mK ATP channels.
    Baharvand B; Dehaj ME; Rasoulian B; Namdari M; Shikhani Y; Kiani AA
    Int J Cardiol; 2009 Jun; 135(2):187-92. PubMed ID: 18584896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hyperbaric oxygen and antianginal agents: experimental and clinical aspects of their interaction].
    Efuni SN; Seriakov VV
    Kardiologiia; 1990 Sep; 30(9):103-5. PubMed ID: 1980325
    [No Abstract]   [Full Text] [Related]  

  • 43. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction.
    Liepinsh E; Vilskersts R; Loca D; Kirjanova O; Pugovichs O; Kalvinsh I; Dambrova M
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):314-9. PubMed ID: 17204911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective inhibition of OCTN2 is more effective than inhibition of gamma-butyrobetaine dioxygenase to decrease the availability of l-carnitine and to reduce myocardial infarct size.
    Liepinsh E; Makrecka M; Kuka J; Cirule H; Makarova E; Sevostjanovs E; Grinberga S; Vilskersts R; Lola D; Loza E; Stonans I; Pugovics O; Dambrova M
    Pharmacol Res; 2014 Jul; 85():33-8. PubMed ID: 24836867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes in enzyme activity in extra-infarct portions of the myocardium after administration of nitroglycerin].
    Cherpachenko NM; Afonskaia NI; Ostrogorskiĭ IuM; Vikhert AM; Ruda MIa
    Kardiologiia; 1984 Apr; 24(4):29-33. PubMed ID: 6427507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of preoperative L-carnitine supplementation on myocardial metabolism during aorto-coronary bypass surgery.
    Böhles H; Noppeney T; Akcetin Z; Rein J; von der Emde J
    Z Kardiol; 1987; 76 Suppl 5():14-8. PubMed ID: 3501644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of nitroglycerine administered by intravenous infusion upon coronary flow and cardiac metabolism. Continuous study during experimental myocardial infarction].
    Cahn J; Angignard J; Pawelec C; Lebeau M; Weber S
    Nouv Presse Med; 1979 Jan; 8(4):239-49. PubMed ID: 122014
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacological preconditioning with L-carnitine: relevance to myocardial hemodynamic function and glycogen and lactate content.
    Najafi M; Javidnia A; Ghorbani-Haghjo A; Mohammadi S; Garjani A
    Pak J Pharm Sci; 2010 Jul; 23(3):250-5. PubMed ID: 20566435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction of infarct size by early use of oral propranolol and verapamil in acute myocardial infarction.
    Gupta RC; Sharma SK; Arora YK; Tripathi K
    J Assoc Physicians India; 1985 Sep; 33(9):577-80. PubMed ID: 4093403
    [No Abstract]   [Full Text] [Related]  

  • 50. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog.
    Kingma JG; Denniss AR; Hearse DJ; Downey JM; Yellon DM
    Circulation; 1987 Jun; 75(6 Pt 2):V25-33. PubMed ID: 3568337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myocardial carnitine deficiency in acute myocardial infarction.
    Spagnoli LG; Corsi M; Villaschi S; Palmieri G; Maccari F
    Lancet; 1982 Jun; 1(8286):1419-20. PubMed ID: 6123712
    [No Abstract]   [Full Text] [Related]  

  • 52. [Cardioprotective effect of carnitine and its synthetic analog 3-(2,2,2-trimethylhydrazinium) propionate in rats with experimental myocardial infarction].
    Ianson TM; Bauman VR; Grom NP; Kienkas IA; Kalvin'sh IIa
    Vopr Med Khim; 1988; 34(4):122-5. PubMed ID: 3195125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study of anti-ischemic action of carnitine chloride and its effects on the effectiveness of antianginal agents].
    Tishkin VS; Dunaev VV; Kryzhanovskiĭ SA; Riabinin VA; Favoritov VN; Danilovich MI; Kacharava VG
    Kardiologiia; 1990 Oct; 30(10):89-91. PubMed ID: 2127064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The cardioprotective action of carnitine and its structural analog 3-(2,2,2-trimethylhydrazine)propionate on cardiac energy metabolism in experimental occlusion of the coronary artery in rats].
    Ratunova TM; Bauman VR; Kalvin'sh IIa
    Farmakol Toksikol; 1989; 52(5):24-7. PubMed ID: 2599072
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection of ischemic myocardium in experimental animals and in man: a review.
    Bolli R
    Cardiovasc Res Cent Bull; 1982; 21(1):1-33. PubMed ID: 6127160
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of carnitine on size limitation of experimental myocardial infarct.
    Ura K; Hironaka Y; Sakurai I
    Am J Cardiovasc Pathol; 1990; 3(2):131-42. PubMed ID: 2264986
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.